SCHEMBL2880952

SCHEMBL2880952

CCOC(=O)CN(Cc1ccc(OC)cc1OC)Cc1nc(N(C(=O)OC(C)(C)C)c2ccccc2)sc1C(=O)OCC

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
ALDH1A1 P00352 6/20 0.37
KDM4E B2RXH2 3/20 0.37
POLB P06746 2/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 4/20 0.36
MEN1 O00255 2/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
HPGD P15428 1/20 0.34
LMNA P02545 4/20 0.34
HTT P42858 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
NR1D1 P20393 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2883109 0.81 CDC7 (0.48) MAPTALDH1A1KDM4EPOLBTSHR
SCHEMBL2887958 0.81 POLB (0.41) MAPTALDH1A1KDM4EPOLBTSHR
SCHEMBL2884704 0.81 POLB (0.44) MAPTALDH1A1KDM4EPOLBTSHR
SCHEMBL2884018 0.81 ALDH1A1 (0.42) MAPTALDH1A1KDM4EPOLBTSHR
SCHEMBL2881044 0.80 POLB (0.43) MAPTALDH1A1KDM4EPOLBTSHR
SCHEMBL2883557 0.80 PTPN11 (0.47) MAPTALDH1A1KDM4EPOLBTSHR
SCHEMBL2882201 0.79 PTPN11 (0.40) MAPTALDH1A1KDM4EPOLBTSHR
SCHEMBL2887022 0.79 PTPN11 (0.46) MAPTALDH1A1KDM4EPOLBTSHR
SCHEMBL2881636 0.78 HPGD (0.45) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL2881201 0.78 PTPN11 (0.52) MAPTALDH1A1KDM4EPOLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124489-B1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2020-07-15 EP disclosed
EP-3124489-A1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS Fibrogen, Inc. (US) 2017-02-01 EP disclosed
EP-2016078-B1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2016-06-15 EP disclosed
US-7696223-B2 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF) FIBROGEN, INC. (US) 2010-04-13 US disclosed
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF FIBROGEN, INC. 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF HIF1AN, HIF1A, EGLN2 MAPT 2965/4885ALDH1A1 1047/4885KDM4E 754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.